United States Agency for International Development (USAID) Selects the Caris Foundation to Lead Project for 4.2 Million
People in Haiti
IRVING, Texas, Dec. 18, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today congratulated Caris Foundation International, a subsidiary of Caris Foundation which is a non-profit, private foundation founded by the David D. Halbert family, on entering a cooperative agreement with the United States Agency for International Development (USAID) to bolster health care in Haiti through a $98.5 million investment over the next four years.
Called Project ‘Santé’ (“Health” in Haitian Kreyol), the initiative will be implemented as a consortium with Caris Foundation International as the leader, Catholic Medical Mission Board and the Haitian Health Foundation, with the goal of assisting, strengthening and expanding essential health services that ultimately serve up to 4.2 million Haitian people. The project will expand and support the work of more than 160 hospitals and clinics nationally to provide quality care.
“Our vision has been to find actionable ways to improve human health across all geographies and economic levels, and both the Caris Foundation and Caris Life Sciences aim to accomplish these goals,” said Mr. Halbert, Founder of Caris Foundation and Chairman and Chief Executive Officer of Caris Life Sciences. “The Caris Foundation’s objective is to help relieve human suffering worldwide. Caris Life Sciences is focused on improving treatment of cancer and other disorders by better understanding the molecular science of each patient’s disease. This grant from USAID will help address a dire medical need and help aid and empower the people of Haiti. I am very proud and honored that the U.S. and Haitian governments have recognized the important work and impact of our Foundation.”
USAID is the lead U.S. Government agency that works to end extreme global poverty and enable resilient, democratic societies to realize their potential.
About Caris Foundation
Caris Foundation is a non-profit, private foundation that aids and empowers impoverished people to alleviate as much human suffering as possible. Caris Foundation focuses its efforts to establish a local presence within communities in order to understand the people’s basic needs and implement solutions that are culturally relevant and sustainable. The foundation was founded and is solely funded by the Halbert family. Headquartered in Colleyville, Texas, Caris Foundation provides medical and empowerment services in Haiti, Kenya and other areas across the globe in need of help. Learn more at www.CarisFoundation.org.
About Caris Life Sciences®
Caris Life Sciences® is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation, and the world’s leading immunotherapy diagnostic expert. Caris Molecular Intelligence®, the company’s Comprehensive Genomic Profiling Plus (CGP+) molecular testing service, assesses DNA, RNA and proteins, including microsatellite instability (MSI), total mutational load (TML) and PD-L1, to reveal a molecular blueprint to guide more precise and personalized treatment decisions. The ADAPT Biotargeting System, the company’s revolutionary and unbiased profiling platform, is currently being utilized for drug target identification, therapeutic discovery and development, fixed tissue-based companion diagnostics, blood-based cancer screening and biomarker identification. Headquartered in Irving, Texas, Caris Life Sciences offers services throughout the U.S., Europe and other international markets. To learn more, please visit www.CarisLifeSciences.com.